Stock Analysis on Net
Stock Analysis on Net

Allergan PLC (NYSE:AGN)

This company has been moved to the archive! The financial data has not been updated since May 7, 2020.

Adjustments to Financial Statements

Microsoft Excel

Adjustments to Current Assets

Allergan PLC, adjusted current assets

US$ in thousands

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Current assets 11,126,700 6,475,400 11,376,700 17,857,900 8,615,400
Adjustments
Add: Allowance for doubtful accounts 110,800 101,700 93,000 75,700 80,600
After Adjustment
Adjusted current assets 11,237,500 6,577,100 11,469,700 17,933,600 8,696,000

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).


The liquidity position of the entity exhibited significant volatility between 2015 and 2019. Both reported and adjusted current assets followed a similar trajectory, characterized by a sharp spike in 2016, a multi-year decline reaching a trough in 2018, and a substantial recovery by the end of 2019.

Asset Volatility and Trend Analysis
Current assets increased dramatically from 8,615,400 thousand US$ in 2015 to a peak of 17,857,900 thousand US$ in 2016. This was followed by a period of contraction over the next two years, with assets falling to 11,376,700 thousand US$ in 2017 and further declining to a period low of 6,475,400 thousand US$ in 2018. A recovery was observed in 2019, as current assets rose to 11,126,700 thousand US$.
Analysis of Financial Adjustments
A consistent positive adjustment is applied to the current assets across the entire five-year period. The delta between reported current assets and adjusted current assets began at 80,600 thousand US$ in 2015 and grew steadily each year, reaching 110,800 thousand US$ by 2019. This indicates a persistent and increasing upward revision to the reported liquidity figures.
Relative Impact of Adjustments
The impact of the adjustments became more pronounced during periods of lower liquidity. In 2018, when current assets were at their lowest reported level, the adjustment of 101,700 thousand US$ represented a larger percentage of the total asset base compared to the peak asset year of 2016, where the 75,700 thousand US$ adjustment had a minimal relative effect.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Adjustments to Total Assets

Allergan PLC, adjusted total assets

US$ in thousands

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Total assets 94,699,100 101,787,600 118,341,900 128,986,300 135,840,700
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1 — 356,873 382,081 290,222 162,581
Add: Allowance for doubtful accounts 110,800 101,700 93,000 75,700 80,600
Less: Deferred tax assets2 576,900 1,063,700 319,100 233,300 49,500
After Adjustment
Adjusted total assets 94,233,000 101,182,473 118,497,881 129,118,922 136,034,381

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

2 Deferred tax assets. See details »


A consistent downward trend is observed in both total assets and adjusted total assets over the five-year period from 2015 to 2019. Total assets decreased from 135,840,700 thousand US$ in 2015 to 94,699,100 thousand US$ by 2019, representing a substantial reduction in the organization's asset base.

Asset Base Contraction
The decline in total assets was continuous year-over-year. The most significant absolute decrease occurred between 2017 and 2018, where assets fell by approximately 16.5 billion US$. This trajectory indicates a systematic reduction in the scale of the balance sheet.
Adjustment Variance Analysis
Between 2015 and 2017, adjusted total assets remained marginally higher than reported total assets. However, a shift occurred in 2018, where adjusted total assets began to fall below the reported total assets. In 2018, the adjusted figure was approximately 605 million US$ lower than the total assets, a trend that persisted into 2019 with a variance of approximately 466 million US$.
Correlation of Metrics
The movements of total assets and adjusted total assets are highly correlated, moving in the same direction throughout the observed period. The narrowing and subsequent inversion of the gap between reported and adjusted figures suggest changes in the nature or valuation of the adjustments applied to the balance sheet over time.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Adjustments to Current Liabilities

Allergan PLC, adjusted current liabilities

US$ in thousands

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Current liabilities 11,070,700 5,727,900 9,848,100 7,874,700 8,328,300
Adjustments
Less: Current accrued product warranties — — — — 7,600
Less: Current restructuring reserve 12,700 71,600 132,800 86,200 110,400
After Adjustment
Adjusted current liabilities 11,058,000 5,656,300 9,715,300 7,788,500 8,210,300

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).


Current liabilities exhibit significant volatility over the five-year period ending December 31, 2019. The obligations fluctuate from a low of approximately 5.7 billion US dollars in 2018 to a peak of over 11 billion US dollars in 2019, indicating substantial shifts in short-term financing or operational obligations.

Liability Trend Analysis
A non-linear progression is observed in total current liabilities. Following a slight decrease in 2016 and an increase in 2017, there was a sharp contraction in 2018, where liabilities fell to 5,727,900 thousand US dollars. This was immediately followed by a significant surge in 2019, with liabilities nearly doubling to reach 11,070,700 thousand US dollars.
Impact of Adjustments
Adjusted current liabilities consistently mirror the trajectory of reported current liabilities, maintaining a slightly lower valuation across all periods. The variance between the reported and adjusted figures peaked in 2017 at 132,800 thousand US dollars and reached its minimum in 2019 at 12,700 thousand US dollars.
Relative Adjustment Magnitude
The magnitude of the adjustments is minimal relative to the total balance. By 2019, the adjustment represents approximately 0.11% of the total current liabilities, suggesting that the adjustments have a negligible impact on the overall liquidity profile of the entity.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Adjustments to Total Liabilities

Allergan PLC, adjusted total liabilities

US$ in thousands

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Total liabilities 36,502,700 36,656,600 44,504,800 52,785,800 59,251,400
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)1 — 356,873 382,081 290,222 162,581
Less: Deferred tax liabilities2 4,363,700 5,501,800 6,352,400 12,969,100 7,985,700
Less: Deferred revenue 26,600 36,100 37,900 15,700 18,200
Less: Accrued product warranties 29,200 27,900 28,700 28,100 36,000
Less: Restructuring reserve 23,500 85,800 185,900 108,200 145,300
After Adjustment
Adjusted total liabilities 32,059,700 31,361,873 38,281,981 39,954,922 51,228,781

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Deferred tax liabilities. See details »


An analysis of the liability structure between 2015 and 2019 reveals a consistent downward trend in both reported and adjusted total liabilities. Total liabilities decreased from approximately 59.25 billion US dollars in 2015 to 36.50 billion US dollars by the end of 2019, representing a significant reduction in overall obligations over the five-year period.

Total Liabilities Trend
A steady decline is observed from 2015 through 2018, with the most substantial reductions occurring between 2016 and 2018. By 2019, the rate of decline slowed significantly, indicating a stabilization of total liabilities at approximately 36.50 billion US dollars.
Adjusted Total Liabilities Trend
Adjusted total liabilities followed a general downward trajectory, starting at 51.23 billion US dollars in 2015 and reaching a low of 31.36 billion US dollars in 2018. In contrast to the reported total liabilities, the adjusted figures exhibited a slight reversal in 2019, increasing to 32.06 billion US dollars.
Analysis of Liability Adjustments
The variance between reported total liabilities and adjusted total liabilities remained substantial throughout the period, with adjusted figures consistently remaining lower. The widest discrepancy was noted in 2016, where the adjustment reduced reported liabilities by approximately 12.83 billion US dollars. From 2017 onward, this gap narrowed progressively, suggesting a reduction in the impact of the adjustments relative to the total liability balance.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Adjustments to Stockholders’ Equity

Allergan PLC, adjusted shareholders’ equity

US$ in thousands

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Shareholders’ equity 58,173,600 65,114,100 73,821,100 76,192,700 76,591,400
Adjustments
Less: Deferred taxes1 (3,786,800) (4,438,100) (6,033,300) (12,735,800) (7,936,200)
Add: Allowance for doubtful accounts 110,800 101,700 93,000 75,700 80,600
Add: Deferred revenue 26,600 36,100 37,900 15,700 18,200
Add: Accrued product warranties 29,200 27,900 28,700 28,100 36,000
Add: Restructuring reserve 23,500 85,800 185,900 108,200 145,300
Add: Noncontrolling interest 22,800 16,900 16,000 7,800 (2,100)
After Adjustment
Adjusted total equity 62,173,300 69,820,600 80,215,900 89,164,000 84,805,600

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 Deferred taxes. See details »


A consistent decline in equity levels is observed between 2015 and 2019. Both the reported shareholders' equity and the adjusted total equity exhibit a downward trajectory, with the contraction becoming more pronounced in the final two years of the period.

Shareholders' Equity Trend
The reported shareholders' equity demonstrates a steady contraction over the five-year period. Starting at 76,591,400 thousand US$ in 2015, the value decreased to 58,173,600 thousand US$ by 2019. This represents a total reduction of approximately 24% over the analyzed timeframe, with the most significant annual drops occurring between 2017 and 2019.
Adjusted Total Equity Trend
Adjusted total equity experienced a brief increase in 2016, reaching a peak of 89,164,000 thousand US$, before entering a period of sustained decline. By 2019, this figure fell to 62,173,300 thousand US$. While the adjusted figures remained higher than the reported equity throughout the period, they followed a similar downward path after 2016.
Analysis of Equity Adjustments
A positive variance is maintained between adjusted total equity and reported shareholders' equity across all years. However, the magnitude of this adjustment narrowed significantly over time. The gap peaked in 2016 at approximately 12,971,300 thousand US$ and contracted to approximately 3,999,700 thousand US$ by 2019, indicating a diminishing impact of the adjustments applied to the equity balance.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Adjustments to Capitalization Table

Allergan PLC, adjusted capitalization table

US$ in thousands

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Current portion of long-term debt and capital leases 4,532,500 868,300 4,231,800 2,797,900 2,432,800
Long-term debt and capital leases, excluding current portion 18,116,500 22,929,400 25,843,500 29,970,800 40,293,400
Total reported debt 22,649,000 23,797,700 30,075,300 32,768,700 42,726,200
Shareholders’ equity 58,173,600 65,114,100 73,821,100 76,192,700 76,591,400
Total reported capital 80,822,600 88,911,800 103,896,400 108,961,400 119,317,600
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)1 — 356,873 382,081 290,222 162,581
Add: Current portion of lease liability, operating2 124,400 — — — —
Add: Lease liability, operating, excluding current portion3 446,100 — — — —
Adjusted total debt 23,219,500 24,154,573 30,457,381 33,058,922 42,888,781
Adjustments to Equity
Less: Deferred taxes4 (3,786,800) (4,438,100) (6,033,300) (12,735,800) (7,936,200)
Add: Allowance for doubtful accounts 110,800 101,700 93,000 75,700 80,600
Add: Deferred revenue 26,600 36,100 37,900 15,700 18,200
Add: Accrued product warranties 29,200 27,900 28,700 28,100 36,000
Add: Restructuring reserve 23,500 85,800 185,900 108,200 145,300
Add: Noncontrolling interest 22,800 16,900 16,000 7,800 (2,100)
Adjusted total equity 62,173,300 69,820,600 80,215,900 89,164,000 84,805,600
After Adjustment
Adjusted total capital 85,392,800 93,975,173 110,673,281 122,222,922 127,694,381

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Current portion of lease liability, operating. See details »

3 Lease liability, operating, excluding current portion. See details »

4 Deferred taxes. See details »


A consistent contraction in the overall capital structure is observed from 2015 through 2019. The entity experienced a systematic reduction in both debt obligations and equity, leading to a significant decrease in total capitalization over the five-year period.

Debt Obligations
A strong downward trend in leverage is evident. Total reported debt decreased from 42,726,200 thousand US$ in 2015 to 22,649,000 thousand US$ by 2019, representing a reduction of approximately 47%. Adjusted total debt mirrors this trajectory, declining from 42,888,781 thousand US$ to 23,219,500 thousand US$ over the same period. The adjusted debt figures remain consistently higher than the reported debt, though the variance between the two narrowed over time.
Equity Analysis
Shareholders' equity exhibited a general decline, although the trajectory differed between reported and adjusted figures. Reported equity fell from 76,591,400 thousand US$ in 2015 to 58,173,600 thousand US$ in 2019. In contrast, adjusted total equity peaked in 2016 at 89,164,000 thousand US$ before entering a steady decline to 62,173,300 thousand US$ by 2019. The adjusted equity values remained significantly higher than the reported equity throughout the period, suggesting substantial positive adjustments to the equity base.
Total Capitalization
The total capital base contracted substantially. Total reported capital declined from 119,317,600 thousand US$ in 2015 to 80,822,600 thousand US$ in 2019. Similarly, adjusted total capital decreased from 127,694,381 thousand US$ to 85,392,800 thousand US$. This overall reduction in capitalization indicates a significant downsizing of the balance sheet, driven by the aggressive repayment of debt and the gradual erosion of equity.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Adjustments to Revenues

Allergan PLC, adjusted net revenues

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Net revenues 16,088,900 15,787,400 15,940,700 14,570,600 15,071,000
Adjustment
Add: Increase (decrease) in deferred revenue (9,500) (1,800) 22,200 (2,500) (8,100)
After Adjustment
Adjusted net revenues 16,079,400 15,785,600 15,962,900 14,568,100 15,062,900

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).


An analysis of the revenue streams from 2015 to 2019 reveals a period of fluctuation characterized by moderate volatility followed by a gradual recovery. Net revenues experienced a decline in 2016 before reaching a peak in 2019, reflecting a non-linear growth trajectory over the five-year period.

Revenue Performance Trends
Net revenues decreased from 15.07 billion USD in 2015 to 14.57 billion USD in 2016. This was followed by a significant recovery in 2017, reaching 15.94 billion USD. A slight contraction occurred in 2018 to 15.79 billion USD, before the highest recorded value of 16.09 billion USD was achieved in 2019.
Analysis of Revenue Adjustments
The variance between net revenues and adjusted net revenues remains immaterial relative to the total revenue volume. In most years, the adjusted net revenues are slightly lower than the reported net revenues, as seen in 2015, 2016, 2018, and 2019. The only exception occurred in 2017, where adjusted net revenues exceeded net revenues by approximately 22.2 million USD.
Adjustment Magnitude and Stability
The difference between the two metrics is minimal, generally representing a fraction of a percentage of total revenue. This suggests that the adjustments made to the financial statements are not driven by volatile or significant one-time events, indicating a high degree of consistency between statutory reporting and adjusted financial performance.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Adjustments to Reported Income

Allergan PLC, adjusted net income (loss) attributable to shareholders

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Net income (loss) attributable to shareholders (5,271,000) (5,096,400) (4,125,500) 14,973,400 3,915,200
Adjustments
Add: Deferred income tax expense (benefit)1 (660,900) (1,262,000) (7,788,700) (2,045,700) (1,811,600)
Add: Increase (decrease) in allowance for doubtful accounts 9,100 8,700 17,300 (4,900) 75,800
Add: Increase (decrease) in deferred revenue (9,500) (1,800) 22,200 (2,500) (8,100)
Add: Increase (decrease) in accrued product warranties 1,300 (800) 600 (300) 36,000
Add: Increase (decrease) in restructuring reserve (62,300) (100,100) 77,700 (35,200) 34,200
Less: Income (loss) from discontinued operations, net of tax — — (402,900) 15,914,500 6,787,700
Add: Other comprehensive income (loss), net of tax (138,000) (512,500) 2,959,100 (544,300) (28,700)
Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest 5,900 10,200 6,600 6,100 4,200
After Adjustment
Adjusted net income (loss) (6,125,400) (6,954,700) (8,427,800) (3,567,900) (4,570,700)

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 Deferred income tax expense (benefit). See details »


The financial performance from 2015 to 2019 exhibits a significant divergence between reported net income and adjusted net income, particularly in the early part of the period. While reported net income showed an initial surge in 2016, the adjusted figures remained consistently negative throughout the five-year duration, indicating that underlying operational performance differed substantially from GAAP reporting.

Reported Net Income Volatility
A sharp increase in reported net income occurred between 2015 and 2016, peaking at approximately 14.97 billion US dollars. However, a pivot occurred in 2017, marking the beginning of a sustained period of net losses. These losses deepened slightly over the subsequent three years, reaching approximately 5.27 billion US dollars by December 31, 2019.
Adjusted Net Income Trends
Adjusted net income remained in negative territory for the entire analysis period. After reaching a maximum loss of approximately 8.43 billion US dollars in 2017, a gradual trend of improvement is observed. The adjusted losses narrowed over the following two years, declining to approximately 6.13 billion US dollars by the end of 2019.
Analysis of Financial Adjustments
The most pronounced discrepancy between reported and adjusted figures is observed in 2016, where a reported profit of 14.97 billion US dollars contrasted with an adjusted loss of 3.57 billion US dollars. This gap suggests the impact of substantial non-recurring gains or accounting adjustments that inflated the reported net income but were excluded from the adjusted metrics to provide a view of recurring performance. Conversely, from 2017 to 2019, the reported losses were consistently smaller than the adjusted losses, indicating that specific non-recurring items acted to offset some of the operational losses in the GAAP presentation.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?